480 filings
Page 15 of 24
6-K
ACST
Acasti Pharma Inc.
5 Jun 18
Acasti Pharma Appoints Brian Groch as Chief Commercial Officer
12:00am
D
ACST
Acasti Pharma Inc.
25 May 18
$837.55K in equity / options / securities to be acquired, sold $372.64K, 1 investor
12:00am
6-K
ACST
Acasti Pharma Inc.
18 May 18
Current report (foreign)
8:44am
6-K
ACST
Acasti Pharma Inc.
14 May 18
Acasti Pharma Announces Full Exercise of Over-Allotment Option
2:32pm
6-K
ACST
Acasti Pharma Inc.
9 May 18
Acasti Pharma Announces Closing of $10 Million Underwritten Offering
5:17pm
6-K
ACST
Acasti Pharma Inc.
27 Apr 18
Acasti Pharma Appoints Donald Olds to its Board of Directors and Audit Committee
8:00am
6-K
ACST
Acasti Pharma Inc.
24 Apr 18
Acasti Pharma Announces Overnight Marketed Canadian Public Unit Offering
12:00am
6-K
ACST
Acasti Pharma Inc.
24 Apr 18
Acasti Pharma Prices CDN$10 Million Underwritten Offering in Canada
12:00am
6-K
ACST
Acasti Pharma Inc.
2 Apr 18
Acasti Pharma Announces Issuance of Common Shares in Payment of Outstanding Interest under Debentures
12:00am
EFFECT
ACST
Acasti Pharma Inc.
16 Mar 18
Notice of effectiveness
12:00am
CORRESP
ACST
Acasti Pharma Inc.
15 Mar 18
Correspondence with SEC
12:00am
6-K
ACST
Acasti Pharma Inc.
14 Mar 18
Acasti Pharma Announces First Patient Randomized in Pivotal TRILOGY Phase 3 Program
12:00am
UPLOAD
ACST
Acasti Pharma Inc.
12 Mar 18
Letter from SEC
12:00am
F-3
ACST
Acasti Pharma Inc.
6 Mar 18
Shelf registration (foreign)
12:00am
424B3
ACST
Acasti Pharma Inc.
15 Feb 18
Prospectus supplement
12:00am
6-K
ACST
Acasti Pharma Inc.
14 Feb 18
Acasti Pharma Reports Third Quarter FY 2018 Financial Results
12:00am
6-K
ACST
Acasti Pharma Inc.
14 Feb 18
Current report (foreign)
12:00am
SC 13G/A
ACST
Acasti Pharma Inc.
13 Feb 18
Acasti Pharma Inc.
12:00am
6-K
ACST
Acasti Pharma Inc.
22 Jan 18
Acasti Pharma Announces the Closing of Over-Allotment
12:00am
424B3
ACST
Acasti Pharma Inc.
18 Jan 18
Prospectus supplement
12:00am